These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6536458)

  • 21. Influence of age on lithium therapy.
    Slater V; Milanes F; Talcott V; Okafor KC
    South Med J; 1984 Feb; 77(2):153-4, 158. PubMed ID: 6701582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Further considerations on the use of lithium carbonate and the renal and thyroid disorders resulting from it].
    Chouinard G
    Union Med Can; 1980 Feb; 109(2):221-6, 304. PubMed ID: 6774458
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lithium in periodic psychoses. Report on 10 years in 34 persons].
    Beloncle M; Martin A; Masson JM; Voisinet C
    Ann Med Psychol (Paris); 1982 Mar; 140(3):369-74. PubMed ID: 6814321
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variants.
    Serretti A; Lorenzi C; Lilli R; Mandelli L; Pirovano A; Smeraldi E
    Am J Med Genet; 2002 May; 114(4):370-9. PubMed ID: 11992559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of hereditary, clinical and pharmacokinetic factors for the prediction of lithium prophylactic effect. WHO Collaborative Study.
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):iii-vii. PubMed ID: 2501824
    [No Abstract]   [Full Text] [Related]  

  • 26. Li-Na counterflow in families of schizo-affective patients.
    Shaughnessy R; Dorus E; Pandey GN; Harris J; Davis JM
    Biol Psychiatry; 1982 May; 17(5):631-3. PubMed ID: 7093399
    [No Abstract]   [Full Text] [Related]  

  • 27. Memory functions during lithium therapy.
    Ghadirian AM; Engelsmann F; Ananth J
    J Clin Psychopharmacol; 1983 Oct; 3(5):313-5. PubMed ID: 6630592
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic drug monitoring: lithium levels.
    Coffman NB; Fernandes JJ
    J Am Osteopath Assoc; 1992 Jul; 92(7):907-9. PubMed ID: 1429051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prophylactic lithium treatment in affective disorders and the possibilities of the outcome prediction.
    Hanus H; Zapletălek M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1984; 27(1):5-75. PubMed ID: 6599636
    [No Abstract]   [Full Text] [Related]  

  • 30. Recent advances in the use of lithium.
    Cade JF
    Aust N Z J Psychiatry; 1971 Mar; 5(1):3-4. PubMed ID: 5291040
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lithium: principles and rules of use].
    Pinabel F; Hardy P
    Rev Prat; 1999 Nov; 49(18):2053-9. PubMed ID: 10626495
    [No Abstract]   [Full Text] [Related]  

  • 32. Neurological sequelae of lithium therapy.
    Mahy Ge
    West Indian Med J; 1984 Dec; 33(4):272-4. PubMed ID: 6523856
    [No Abstract]   [Full Text] [Related]  

  • 33. Lithium concentration correlates with QTc in patients with psychosis.
    Mamiya K; Sadanaga T; Sekita A; Nabeyama Y; Yao H; Yukawa E
    J Electrocardiol; 2005 Apr; 38(2):148-51. PubMed ID: 15892025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subjective side effects of lithium carbonate: a longitudinal study.
    Duncavage MB; Nasr SJ; Altman EG
    J Clin Psychopharmacol; 1983 Apr; 3(2):100-2. PubMed ID: 6404952
    [No Abstract]   [Full Text] [Related]  

  • 35. Lithium treatment of psychotic children and adolescents. A controlled clinical trial.
    Gram LF; Rafaelsen OJ
    Acta Psychiatr Scand; 1972; 48(3):253-60. PubMed ID: 4617490
    [No Abstract]   [Full Text] [Related]  

  • 36. Who responds to prophylactic lithium therapy?
    Abou-Saleh MT
    Br J Psychiatry Suppl; 1993 Sep; (21):20-6. PubMed ID: 8217063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Instant lithium monitoring: a clinical revolution in the making.
    Srinivasan DP; Birch NJ
    Br J Clin Pract; 1996; 50(7):386-8. PubMed ID: 9015912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Appropriateness of therapeutic drug monitoring for lithium.
    Ratanajamit C; Soorapan S; Doang-ngern T; Waenwaisart W; Suwanchavalit L; Suwansiri S; Jantasaro S; Yanate I
    J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The use of carbamazepine in affective disorders].
    Beresewicz M
    Psychiatr Pol; 1994; 28(4):455-66. PubMed ID: 7972553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetic study of delayed-action lithium in affective psychoses].
    Molcan J; Rakús A; Motýlová A
    Agressologie; 1980; 21(A):11-4. PubMed ID: 7246873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.